When Alessandro Barbera was rushed to a California hospital with infant botulism in October, his father had barely heard of ...
US FDA Grants Priority Review to Bristol Myers Squibb's Application for Opdivo (nivolumab) Plus Chemotherapy Combination for Classic Hodgkin Lymphoma ...
17hon MSN
How to avoid hypothermia this winter
Here’s what hypothermia is, what causes it and how it is typically treated if it affects you or someone you love.
Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...
The global intravenous (IV) fluid bags market is projected to grow at a compound annual growth rate (CAGR) of approximately 6 ...
Caffeine sticks offer a quick, travel-friendly energy boost with fewer sugars and added benefits—but are they safe and ...
New Scientist on MSN
Timing cancer drug delivery around our body clock may boost survival
The time of day that cancer drugs are administered could make a big difference to a patient's outcomes, and would be a ...
How to make wire jewelry To make the moon you can use any type of stone you want. I'm not trained, I just follow instinct, I work according to personal preferences like a way of entertainment. I'm ...
Based on phase 3 trial data, the FDA accepted an sBLA for nivolumab plus AVD for untreated stage III or IV classical Hodgkin lymphoma.
The FDA says 51 infants in 19 states were hospitalized with botulism linked to ByHeart formula. Here’s what we know.
Sibel Health, a leader in wearable biosensing and digital health, today announced that it has been awarded a competitive grant from the U.S. Food and Drug Administration (FDA) to advance towards full ...
Federal health officials on Wednesday expanded an outbreak of infant botulism tied to recalled ByHeart baby formula to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results